Elevance Health Inc. (ELV)
NYSE·Healthcare·Medical - Healthcare Plans
$363.43
+2.07%
Mkt Cap $70.48B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 22, 2026 | $48.20B | $49.49B | +2.68% | $11.03 | $12.58 | +14.05% | — | — |
| Q1 2026 Jan 28, 2026 | $49.84B | $49.31B | -1.07% | $3.10 | $3.33 | +7.42% | — | — |
| Q4 2025 Oct 21, 2025 | $49.38B | $50.71B | +2.70% | $4.93 | $6.03 | +22.31% | — | — |
| Q3 2025 Jul 17, 2025 | $48.19B | $49.78B | +3.29% | $8.91 | $8.84 | -0.79% | — | — |
| Q2 2025 Apr 22, 2025 | $46.30B | $48.89B | +5.60% | $11.41 | $11.97 | +4.91% | — | — |
| Q1 2025 Jan 23, 2025 | $44.95B | $45.44B | +1.09% | $3.80 | $3.84 | +1.05% | — | — |
| Q4 2024 Oct 17, 2024 | $43.47B | $45.15B | +3.86% | $9.66 | $8.37 | -13.35% | — | — |
| Q3 2024 Jul 17, 2024 | $42.99B | $43.65B | +1.53% | $10.01 | $10.12 | +1.10% | — | — |
| Q2 2024 Apr 18, 2024 | $42.49B | $42.58B | +0.20% | $10.53 | $10.64 | +1.04% | — | — |
| Q1 2024 Jan 24, 2024 | $42.09B | $42.65B | +1.31% | $5.55 | $5.62 | +1.26% | — | — |
| Q4 2023 Oct 18, 2023 | $41.97B | $42.85B | +2.08% | $8.45 | $8.99 | +6.39% | — | — |
| Q3 2023 Jul 19, 2023 | $41.50B | $43.67B | +5.23% | $8.80 | $9.04 | +2.73% | — | — |
| Q2 2023 Apr 19, 2023 | $40.83B | $42.17B | +3.28% | $9.26 | $9.46 | +2.16% | — | — |
| Q1 2023 Jan 25, 2023 | $39.77B | $39.93B | +0.39% | $5.20 | $5.23 | +0.58% | — | — |
| Q4 2022 Oct 19, 2022 | $39.29B | $39.94B | +1.65% | $7.15 | $7.53 | +5.31% | — | — |
| Q3 2022 Jul 20, 2022 | $37.91B | $38.63B | +1.89% | $7.74 | $8.04 | +3.88% | — | — |
| Q2 2022 Apr 20, 2022 | $37.39B | $38.09B | +1.87% | $7.81 | $8.25 | +5.63% | — | — |
| Q1 2022 Jan 26, 2022 | $37.33B | $36.58B | -2.00% | $5.11 | $5.14 | +0.59% | — | — |
| Q4 2021 Oct 20, 2021 | $35.30B | $35.82B | +1.47% | $6.37 | $6.79 | +6.59% | — | — |
| Q3 2021 Jul 21, 2021 | $35.32B | $33.85B | -4.16% | $6.33 | $7.03 | +11.06% | — | — |